Annually, congressional appropriations legislation includes language that prevents the U.S. Food and Drug Administration (FDA) from advancing a proposed 2014 regulation that would require pharmaceutical prescribing information (PI) be delivered primarily by digital form instead of paper. As a result, PI continues to be primarily distributed in paper format which is often discarded as unnecessary. The FDA estimates that each year 90 billion pages of prescribing labels are discarded without even being used, and, if they are used, they can be out of date by as much as one year. FDA’s proposed regulation to modernize PI would improve the speed of labeling updates, and thus the speed of patient care delivery; avoid potential negative impact to patients; and reduce hundreds of millions of pounds of unnecessary paper waste discarded each year.
AmerisourceBergen is a member of the Alliance to Modernize Prescribing Information (AMPI) – a group of pharmaceutical stakeholders with a common interest in advancing regulatory or legislative reforms to facilitate the dissemination of FDA-approved pharmaceutical labeling information via modern digital platforms. AMPI is currently collecting pharmacist responses to a brief survey regarding use of electronic vs. paper-based PI. We would greatly appreciate if you can take a few moments to complete the survey which will be helpful in ongoing advocacy efforts with members of Congress! For more information on the issue, please visit AMPI’s website.
Take the survey today!